Close

Hemispherx Biopharma (HEB) Enters Agreement with Emerge Health for Alferon Distribution in Australia, New Zealand

August 11, 2015 9:26 AM EDT Send to a Friend
Hemispherx Biopharma (NYSE: HEB) has executed an agreement with Emerge Health Pty Ltd. ("Emerge") to seek approval of Alferon N ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login